How Fatty Liver Disease Helps Cancer Thrive in the Liver - Cancer Currents Blog

The latest from the NCI Cancer Currents blog

Having trouble viewing this email? View it as a Web page.

How Fatty Liver Disease Helps Cancer Thrive in the Liver 07/06/2023 When colorectal cancer spreads to the liver, it can be very difficult to treat. Cancer is more likely to invade the liver when patients have fatty liver disease. A recent study places the blame on "message bubbles" called extracellular vesicles that are released by the liver. You are subscribed to the latest posts from Cancer Currents: An NCI Cancer Research Blog from the National Cancer Institute. Update your subscriptions.

Stay Connected with the National Cancer Institute
Chat with us: LiveHelp  Call us: 1-800-4-CANCER (1-800-422-6237) SUBSCRIBER SERVICES: Manage Subscriptions  |  Help

 

This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Cancer Institute · BG 9609 MSC 9760 · 9609 Medical Center Drive · Bethesda, MD 20892

Glioblastoma | Pancreatic Cancer | Glioma, Cancer Information Highlights, 07/05/2023

Having trouble viewing this email? View it as a Web page.

Cancer Information Highlights   New from NCI How Some Brain Tumors Hijack the Mind to Grow   Researchers have found that the aggressive brain cancer glioblastoma can take over the formation of new synapses to fuel its own growth. This neural redirection also appears to play a role in the cognitive decline seen in many people with this cancer. Pancreatic Cancer Cells May Survive with the Help of an Energy Alternative to Glucose   A new study finds that pancreatic cancer cells have a ready way to overcome a lack of glucose, something that happens often in this disease. They use another fuel source called uridine. Findings from a related study suggest other cancers do as well. Targeted Drug Shows Promise for Some Low-Grade Gliomas   In a large clinical trial, the targeted drug vorasidenib slowed the growth of low-grade gliomas that had mutations in the IDH1 or IDH2 genes. Vorasidenib is the first targeted drug developed specifically to treat brain tumors.   Also of Interest Colorectal Cancer Prevention Most cases of colorectal cancer are diagnosed after age 50, but new cases in people younger than 50 have been on the rise. Learn about risk factors and protective factors that might affect a person's risk of colorectal cancer. Melanoma Treatment Melanoma is a rare form of skin cancer that is more likely than other types of skin cancer to spread to other parts of the body. Find out about risk factors and symptoms of melanoma and how it is diagnosed and treated. Contact Us for Help Information specialists at NCI's Cancer Information Service (CIS), NCI's contact center, are available to help answer your cancer-related questions in English and Spanish. Reach us by phone, chat, or email.

Stay Connected with the National Cancer Institute
Chat with us: LiveHelp  Call us: 1-800-4-CANCER (1-800-422-6237) SUBSCRIBER SERVICES: Manage Subscriptions  |  Help

 

This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Cancer Institute · BG 9609 MSC 9760 · 9609 Medical Center Drive · Bethesda, MD 20892

What Is Naturopathy?

Naturopathy is a medical system that evolved from a combination of traditional practices and health care approaches popular in Europe

Click here to view in browser. U.S. Department of Health & Human Services  /  National Institutes of Health What Is Naturopathy? Naturopathy is a medical system that evolved from a combination of traditional practices and health care approaches popular in Europe during the nineteenth century. Naturopathic practitioners use many different treatment approaches, including dietary and lifestyle changes, herbs and other dietary supplements, manipulative therapies, and psychotherapy and counseling.   In the United States, naturopathy is practiced by naturopathic physicians, traditional naturopaths, and other health care providers (such as physicians or chiropractors) who offer naturopathic treatments. Education and licensing differ for the three types of practitioners.   Find out more

Connect with NCCIH SUBSCRIBER SERVICES: Manage Preferences/Unsubscribe | Subscription Help

---

This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Center for Complementary and Integrative Health · 9000 Rockville Pike · Bethesda, MD 20892

Lung Cancer Trial of Osimertinib Draws Praise—and Some Criticism - Cancer Currents Blog

The latest from the NCI Cancer Currents blog

Having trouble viewing this email? View it as a Web page.

Lung Cancer Trial of Osimertinib Draws Praise—and Some Criticism 07/05/2023 In the ADAURA clinical trial, people with early-stage lung cancer treated with osimertinib (Tagrisso) after surgery lived longer than people treated with a placebo after surgery. Despite some criticisms about its design, the trial is expected to change patient care. You are subscribed to the latest posts from Cancer Currents: An NCI Cancer Research Blog from the National Cancer Institute. Update your subscriptions.

Stay Connected with the National Cancer Institute
Chat with us: LiveHelp  Call us: 1-800-4-CANCER (1-800-422-6237) SUBSCRIBER SERVICES: Manage Subscriptions  |  Help

 

This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Cancer Institute · BG 9609 MSC 9760 · 9609 Medical Center Drive · Bethesda, MD 20892

Your gift x2 = twice the impact for people with diabetes

Donate today and your donation will go twice as far! View in browser Research Is the Key to Beating Diabetes Your matched donation will support lifesaving research impacting millions living with or affected by diabetes. Match My Donation Your matched donation will fund critical, lifesaving research. Friend Last week, the American Diabetes Association® (ADA) hosted its 83rd Scientific Sessions—the world’s largest gathering of the best minds in diabetes science and care. This year’s meeting of the greatest minds featured presentations on groundbreaking diabetes topics and research findings—research that can help make breakthrough discoveries in our quest to find a cure. We’ve been honored to meet some of our supporters and researchers who care about finding treatments and a cure as much as you do, and we thought you might like to “meet” them, too. Jim and Marlene Ryan gave to fund diabetes research because they know firsthand how critical effective treatments are. After a terminal diagnosis of pulmonary arterial hypertension, Marlene spent an extra five years with her family, and a new treatment made those years possible. Her family is grateful for that time and felt that, since Jim has diabetes, it was important to give that gift to other families of loved ones with diabetes too—that’s why they support ADA. We could not do this work without people like Jim, Marlene, and you. Double My Gift Don’t miss this opportunity to make TWICE the impact —thanks to an extended $100,000 matching gift from an ADA supporter! Your donation today will help fund lifesaving research and impact the lives of millions living with, at risk of, and caring for a loved one with diabetes.   © 2023 American Diabetes Association®. All rights reserved. askada@diabetes.org  |   1‑800‑DIABETES Learn more at diabetes.org. Forward to a Friend  |   Manage Your Communications  |   Unsubscribe